US Stock MarketDetailed Quotes

MRVI Maravai LifeSciences

Watchlist

2.900
-0.120-3.97%

Trading Mar 4 10:37 ET

411.35MMarket Cap-1.74P/E (TTM)

Maravai LifeSciences Stock Forum

Teddy123

Feb 24 07:16

Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio

$Maravai LifeSciences (MRVI.US)$
AI Meets mRNA: How Maravai's Latest Acquisition Reshapes Drug Development

DrC 504

Jan 21 09:34

A DIAMOND IN THE ROUGH

$Maravai LifeSciences (MRVI.US)$ UNDERVALUED FALLING STAR stock swing trade - healthcare - mid cap - 5/9 F-Score - 0.75x relative volume - 1x analyst outperform rating - 2x analysts outperform rating - 2x analysts buy rating - trading at 42% below estimate of its fair value - short to medium term gains 📈

Stock_Drift

Sep 24, 2024 07:16

$Maravai LifeSciences (MRVI.US)$

Moomoo AI

Apr 6, 2024 09:07

Despite Maravai LifeSciences Holdings' significant liabilities, it has net cash, indicating a light debt load. However, its pre-interest and tax loss and declining revenue raise future earnings and balance sheet health concerns.

Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way?

Moomoo AI

Dec 21, 2023 06:11

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 06:02

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 05:43

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 05:42

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Nov 16, 2023 04:32

Analysts project a revenue dip and a reduced price target for Maravai LifeSciences Holdings. Increased investor caution may apply due to expected underperformance.

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Analysts Just Slashed Next Year's Revenue Estimates By 17%

Analysts Notebook

May 23, 2023 08:07

Columns US Top Rating Updates on 5/23: ZM, CVX, WPM, BLD and More

MoffettNathanson Upgrades $Zoom Communications (ZM.US)$ to Market Perform From Underperform, Price Target Is $85
Zoom Video Communications has an average rating of hold and price targets ranging from $65 to $105, according to analysts polled by Capital IQ.
HSBC Upgrades $Chevron (CVX.US)$ to Buy From Hold, Price Target Is $189
Chevron (CVX) has an average rating of outperform and price targets ranging from $161 to $212, according to ...

No comment yet

MRVI Maravai LifeSciences

Maravai LifeSciences Stock Forum

Trending Stocks